| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/12/2000 | EP0794951B1 Processes and intermediates for preparing cis (+) 3-[4,6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline |
| 04/12/2000 | EP0707566B1 Novel structural analogues of vitamin d |
| 04/12/2000 | CN1250445A Sulfamide-metalloprotease inhibitors |
| 04/12/2000 | CN1250370A Aqueous suspension for nasal administration of loteprednol |
| 04/12/2000 | CN1249936A Health food capable of returning youthful vigour |
| 04/12/2000 | CN1051316C Cortinoid derivative, its producing process and medicine containing the same |
| 04/11/2000 | US6048972 Polynucleotide sequences which code for reshaped human monoclonal antibody preferential to interleukins |
| 04/11/2000 | US6048889 Proline derivatives |
| 04/11/2000 | US6048880 Therapy for cytokine sensitive diseases |
| 04/11/2000 | US6048873 Skin disorders |
| 04/11/2000 | US6048858 Heteroring containing a sulfonamide group |
| 04/11/2000 | US6048848 Use of pregnane-diones as analgesic agents |
| 04/11/2000 | US6048844 Treatment of conditions and disease |
| 04/11/2000 | US6048553 Aqueous metal bicarbonate solution useful in treating inflammatory, degenerative and viral diseases |
| 04/11/2000 | US6048526 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor |
| 04/11/2000 | US6048523 Polyester cyclic compounds, their complexes and bonded bodies |
| 04/11/2000 | CA2009503C Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids |
| 04/11/2000 | CA1340955C Stilbene derivatives |
| 04/08/2000 | CA2285120A1 Heterocycles |
| 04/06/2000 | WO2000018919A1 Human kinesin-like motor protein |
| 04/06/2000 | WO2000018915A2 Membrane-associated organizational proteins |
| 04/06/2000 | WO2000018912A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 04/06/2000 | WO2000018895A1 Short peptides which selectively modulate the activity of protein kinases |
| 04/06/2000 | WO2000018794A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 04/06/2000 | WO2000018764A1 Benzimidazolinyl piperidines as cgrp ligands |
| 04/06/2000 | WO2000018760A1 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders |
| 04/06/2000 | WO2000018759A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 04/06/2000 | WO2000018753A1 2-phenylpyran-4-one derivatives |
| 04/06/2000 | WO2000018744A1 Oxazole compounds as prostaglandin e2 agonists or antagonists |
| 04/06/2000 | WO2000018738A1 Benzamide derivatives and their use as cytokine inhibitors |
| 04/06/2000 | WO2000018437A1 Tie2 antagonist antibodies |
| 04/06/2000 | WO2000018432A1 Carbohydrate vaccines for viral diseases |
| 04/06/2000 | WO2000018405A1 Use of prostanoid antagonists for the treatment of primary headache disorders |
| 04/06/2000 | WO2000018398A1 Pharmaceutically active compounds and methods of use thereof |
| 04/06/2000 | WO2000018388A2 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/06/2000 | WO2000018374A1 Controlled release nanoparticulate compositions |
| 04/06/2000 | WO2000018365A2 Fast dissolving orally consumable films |
| 04/06/2000 | WO2000018352A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | WO2000018338A1 Methods and apparatus for improved administration of fentanyl and sufentanil |
| 04/06/2000 | WO2000018230A1 Combination of bisphosphonate and tetracycline |
| 04/06/2000 | WO2000006588B1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS |
| 04/06/2000 | WO1999058162A3 Pharmaceuticals for the imaging of angiogenic disorders |
| 04/06/2000 | WO1999040906A3 Method and composition for treatment of inflammatory conditions |
| 04/06/2000 | CA2794705A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 04/06/2000 | CA2346061A1 Carbohydrate vaccines for viral diseases |
| 04/06/2000 | CA2345641A1 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | CA2345474A1 Oxazole compounds as prostaglandin e2 agonists or antagonists |
| 04/06/2000 | CA2345357A1 Benzimidazolinyl piperidines as cgrp ligands |
| 04/06/2000 | CA2345273A1 Pharmaceutically active compounds and methods of use thereof |
| 04/06/2000 | CA2344658A1 Human kinesin-like motor protein |
| 04/06/2000 | CA2344107A1 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 04/06/2000 | CA2343934A1 Short peptides which selectively modulate the activity of protein kinases |
| 04/06/2000 | CA2343929A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 04/06/2000 | CA2343696A1 Membrane-associated organizational proteins |
| 04/06/2000 | CA2343098A1 Combination of bisphosphonate and tetracycline |
| 04/06/2000 | CA2342603A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/06/2000 | CA2340454A1 Benzamide derivatives and their use as cytokine derivatives |
| 04/06/2000 | CA2338442A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 04/05/2000 | EP0990038A1 New human lysophospholipase |
| 04/05/2000 | EP0989987A1 Spiro-azacyclic derivatives and their use as therapeutic agents |
| 04/05/2000 | EP0989985A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors |
| 04/05/2000 | EP0989982A1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 04/05/2000 | EP0989975A1 Oxazole compounds useful as pge2 agonists and antagonists |
| 04/05/2000 | EP0989853A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/05/2000 | EP0766664B1 Metalloproteinase inhibitors |
| 04/05/2000 | EP0716661B1 Pseudo- and non-peptide bradykinin receptor antagonists |
| 04/05/2000 | CN1249749A Phthalazinones |
| 04/05/2000 | CN1249748A Small molecules useful in treatment of inflamatory disease |
| 04/05/2000 | CN1249745A Vitronectin receptor antagonists |
| 04/05/2000 | CN1249743A Arylsulfonylamino hydroxamic acid derivs |
| 04/05/2000 | CN1249742A Anti-inflammatory compounds |
| 04/05/2000 | CN1249688A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/05/2000 | CN1051086C Heterocycle-condensed morphinoid derivs. and use thereof |
| 04/04/2000 | US6046340 Imidazole containing pseudodipeptide product and compositions containing the same |
| 04/04/2000 | US6046334 Heterocyclic chemical compound |
| 04/04/2000 | US6046309 Macrophage-derived inflammatory mediator (MIP-1α and MIP-1β) |
| 04/04/2000 | US6046232 α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same |
| 04/04/2000 | US6046221 Useful for reducing levels of tumor necrosis factor-alpha in a mammal |
| 04/04/2000 | US6046220 Propynyl or dienyl biaromatic compounds |
| 04/04/2000 | US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/04/2000 | US6046195 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 04/04/2000 | US6046191 Combination |
| 04/04/2000 | US6046162 Suppression of cell proliferation by decorin |
| 04/04/2000 | US6046049 Compound 8 to 30 nucleobases in length targeted to 3' untranslated region of nucleic acid which encodes human phosphatidyl inositol 3' kinase p110 delta isoform found in leukocytes; diagnosis, treatment of related diseases |
| 04/04/2000 | US6045826 Antioxidant/antiaging medicinal or cosmetic mixture for skin disorder prophylaxis |
| 04/04/2000 | US6045809 A drug mixture consisting of prolamines and polymer films derived from prolamines with good bioavailability and therapeutic efficacy; treating inflammation |
| 04/04/2000 | US6045796 Vaccination with peptide of MHC class II molecules for treatment of autoimmune disease |
| 04/04/2000 | US6045792 Human proteins kinases |
| 04/04/2000 | CA2155933C Pulmonary administration of scr1 and other complement inhibitory proteins |
| 04/04/2000 | CA2107432C Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present |
| 04/04/2000 | CA2031129C Chimeric antibody for detection and therapy of infectious and inflammatory lesions |
| 03/30/2000 | WO2000017394A1 Polymorphisms in the human alpha4 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 03/30/2000 | WO2000017393A1 Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 03/30/2000 | WO2000017371A1 Polynucleotide constructs and uses thereof |
| 03/30/2000 | WO2000017370A1 HUMAN COMPLEMENT C3-DEGRADING POLYPEPTIDE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 03/30/2000 | WO2000017361A2 Interferon-epsilon |
| 03/30/2000 | WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 03/30/2000 | WO2000017222A1 31 human secreted proteins |
| 03/30/2000 | WO2000017204A1 INHIBITORS OF p38 |
| 03/30/2000 | WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors |